Breast Pathology Conference | World Cancer Meetings | Vienna | Austria

Theme: Unveiling the potential for faster Breast Cancer Diagnosis

Breast Pathology 2020

Breast Pathology 2020

Important Dates & Deadlines

Category	1^st Round	2^nd Round	Final Deadline
Abstract	March 15, 2020	June 15, 2020	August 25, 2020
Registration	January 30, 2020	May 31, 2020	September 17, 2020

Breast Pathology 2020 along with the support of Editorial Members and Organizing Committee extends its welcome to you during September 17-18, 2020 at Vienna, Austria with the theme “Unveiling the potential for faster breast cancer diagnosis’’.

About Breast Pathology..!!

The pathologist provides vital information central to the deliberations of the multidisciplinary treatment team. Consistency of recording and reporting of key pathology features to support the implementation of best practice treatment. Comprehensive reporting in pathology helps to assure better communication between clinicians, with less likelihood of misinterpretation of findings. As the biology of breast cancer is becoming better understood, and as new treatments emerge, the management of breast cancer is increasingly being tailored according to patient and tumor factors. Providing an accurate understanding of the distinct pathology features of an individual patient’s breast cancer enables treatment protocols to be tailored to tumor characteristics based on the latest evidence.

Breast cancer is cancer that forms in the cells of the breasts. After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States. Breast cancer can occur in both men and women, but it's far more common in women. Substantial support for breast cancer awareness and research funding has helped create advances in the diagnosis and treatment of breast cancer. Breast cancer survival rates have increased, and the number of deaths associated with this disease is steadily declining, largely due to factors such as earlier detection, a new personalized approach to treatment and a better understanding of the disease.

Typically, treatment plans are based on the type of breast cancer, its stage, etc. It basically depends upon other factors as well such as overall health and personal preferences. Drugs used in breast cancer treatment are considered as Systemic Therapies as they can reach cancer cells almost anywhere in the body. Common systemic treatments include Chemotherapy for Breast Cancer, Hormone Therapy for Breast Cancer, and Targeted Therapy for Breast Cancer.

Audience:

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other healthcare professionals interested in the treatment of breast cancer are also invited to attend. Euro Breast Pathology 2020 came up with a theme "Unveiling the potential for faster breast cancer diagnosis"

Conference Highlights:

What is Breast Cancer?

Breast cancer represents a complicated family of diseases for which detection, diagnosis, and multimodal management strategies are continually evolving. With each lesson learned about the biology of these diseases and with each improvement to the standards of care, new questions, challenges, and controversies arise. Therefore, practice-focused education that enables you to integrate the highest-quality methodologies into your clinic is essential.

Target Audience

Women's Healthcare professors, Researchers, and nurses
Cancer center Managers
Vice Presidents or Directors
Brand Manufacturers or Marketers of screening instrumental Products
Professors, Directors or Co-directors
Medical Oncologists, Surgical Oncologists
Teachers seeking educational material
Radiation Oncologists
Surgeons, Gynaecologists
Pathologists
Epidemiologists
Breast cancer Nurses
Trainees in breast pathology
Medical staff & Medical Journalists
Researchers and Students from Academia in the study of Women's health filed
Pharmaceutical researchers
Clinical organizations
Educational institutes
Other healthcare professionals interested in the latest advances and techniques in the field

Objective:

To understand the epidemiology of breast cancer
To understand the risk factors, natural history, and histopathology of breast cancer
To learn the current guidelines for breast cancer screening
To understand mammographic findings significant for breast cancer
To understand when a Breast MRI is indicated

Benefits of Attending the Breast Pathology and Cancer Diagnosis Conference

Network with your peers and world-renowned thought leaders
Ask world-renowned thought leaders your important questions
Apply the latest evidence, therapies, and strategies in your practice
Gain expert perspectives and clarity on areas of clinical uncertainty and controversy
Improve the patient-centered, state-of-the-art care you provide to your patients

Track 1: Breast Cancer - Current Perspective

Breast cancer is cancer that forms in the cells of the breasts. After skin cancer, breast cancer is the most common cancer diagnosed in women across the globe. Breast cancer can occur in both men and women, but it's far more common in women.

Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, and fluid coming from the nipple, a newly-inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.

Breast cancers can start from different parts of the breast.

Most breast cancers begin in the ducts that carry milk to the nipple (ductal cancers)
Some start in the glands that make breast milk (lobular cancers)
There are also other types of breast cancer that are less common like phyllodes tumor and angiosarcoma
A small number of cancers start in other tissues in the breast. These cancers are called sarcomas and lymphomas and are not really thought of as breast cancers.

Related Conferences:

San Antonio Breast Cancer Symposium, December 10 - 14, 2019, San Antonio, USA | UK Interdisciplinary Breast Cancer Symposium, January 27-28, 2020, Birmingham, UK | Advances in Breast Cancer Management, February 07-08, 2020, Florida, USA | 37^th Annual Miami Breast Cancer Conference, March 05-08, 2020, Miami, USA | 11th European Breast Cancer Conference, March 18-20, 2020, Barcelona, Spain | Global Breast Cancer Conference, April 09-11, 2020, Seoul, Korea | ESMO Breast Cancer, May 07-09, 2020, Berlin, Germany | 6^th World Congress on Controversies in Breast Cancer, September 04-06, 2020, Chongqing, China | 2^nd Annual Congress on Breast Cancer Research, September 07-08, 2020, Rome, Italy | 4^th World Congress on Breast Cancer and Women’s Health, September 14-16, 2020, Sydney, Australia | 5^th Global Insight Conference on Breast Cancer, September 24-26,2020, Barcelona, Spain

Related societies and associations:

Track 2: Breast Cancer - Screening, Detection, and Diagnosis

The sooner breast cancer gets diagnosed, the better your odds of getting successful treatment.

That's why it’s important to get mammograms as recommended, to be familiar with how your breasts usually look, and to report any changes to your doctor ASAP. Why?

Breast cancer risk is on the rise: The lifetime risk of a woman getting breast cancer in the U.S. was around 5%, or 1 in 20, in 1940. Now it’s 12% or more than 1 in 8.
Finding breast cancer earlier boosts your survival odds: Women who have breast cancer screening mammograms are much less likely to die from the disease. This depends on:

The quality of the test
Getting screened as often as you need to
Doing what your doctor says afterward

Clinical breast exams and mammography are screening tests. At higher risk breast MRI can also be used for some women. Powerful magnetic field and radio waves are used during Magnetic Resonance Imaging (MRI), which produces detailed images of structures within the breast. If breast cancer is detected either by screening tests or from symptoms diagnostic tests precautionary measures are given to the woman who is suspected of having breast cancer. Diagnostic tests include Mammogram (X-ray of the breast), Breast ultrasound (uses sound waves to produce pictures of structures), Removing a sample of breast cells for testing (biopsy), Breast Magnetic Resonance Imaging (MRI). These diagnostic tests confirm the presence or absence of breast cancer and give more information about breast cancer like whether it has traveled outside the breast or not. Many tests are used to monitor how well therapies are working after the diagnosis of breast cancer. These tests after diagnosis are also used to check any signs of recurrence. These tests include mammography and medical history, physical examination. The patient should visit the doctor every 3 to 6 months for the 3 years after the treatment.

Related Conferences:

Related societies and associations:

Track 3: Breast Cancer - Therapy, Prevention, and Medication

To reduce the chances of developing breast cancer for women at higher risk, healthcare providers may recommend therapy along with one of several medications based upon careful risk assessment. Selective Estrogen Receptor Modulators (SERM) is another name for these medications, these include tamoxifen and raloxifene. Aromatase inhibitors are a group of medications; they are effective for breast cancer prevention. These medications prevent tumor which is known to be responsive to female hormones. The treatment plan to achieve good outcomes is affected by the biology of breast cancer. Breast Therapy includes Mastectomy, breast-sparing surgery and radiation therapy, Chemotherapy, Stereotactic Radiosurgery, Hormone Therapy, and Targeted Therapy.

Related Conferences:

Related societies and associations:

Track 4: Surgical Choices for Breast Cancer

The most common treatment for breast cancer is Surgery; with the removal of as much of the tumors as possible is the main purpose. Different types of surgeries are available. Some type of surgery is a part treatment for most women with breast cancer. Two main types of surgery to remove breast cancer are Breast-Conserving Surgery (BCS) and Mastectomy. During the breast-conserving surgery, most of the breast part containing tumor cells are removed and some part of surrounding tissues is also removed. Mastectomy includes the removal of the entire breast; double mastectomy is also done in some cases in which both the breasts are removed. At the early stages of breast cancer, many women choose between breast-conserving surgery and mastectomy. Women undergoing BCS have the advantage of keeping most of her breast but she will also need radiation. Women opting for mastectomy at earlier stages are less likely to for radiation. Because of the type of breast cancer mastectomy may be the better option for some women.

Related Conferences:

Related societies and associations:

Track 5: Personalized Medicine - A Redefined Treatment

Furnishing the proper treatment to the right person at the right time is the primary goal of personalized medicine. Precision medicine is another term used for personalized medicine; it is a medical procedure in which patients are segregated into different groups. Based upon their predicted response or risk to disease after medical decisions, practices, interventions or products given to individual patients. Personal genetic or protein profiles are integrated for personalized medicine so that healthcare can be strengthened at a more personalized level. A positive effect on patient’s disease is the main target of personalized medicine so that effective treatment for a particular disease can be achieved. Knowledge of patients’ genetic profiles is required for proper medication or therapy. For the development of personalized medicine for breast cancer, knowledge of genetic profile is taken into consideration.

Related Conferences:

Related societies and associations:

Track 6: Breast Cancer - Clinical Trials

Clinical trials are research studies, with the help of which doctors identify the best treatments with minimal side effects. For clinical trials, people agree on new therapies. The overall standard of care can be improved with the help of these studies. Side effects are there for all treatment procedures for breast cancer and for some diagnosis tests as well. Clinical trials or research trials are done to figure out the side effects of treatment as well as the success rate of the new treatment procedure. Clinical trials are done after the preclinical trials. Preclinical trials are done on mice, as they suggest whether it will be safe for people to exposure a new treatment or not. Security and advantages of new medications can be tested with the help of clinical trials.

Related Conferences:

Related societies and associations:

Track 7: Breast Cancer Stages

The most common tool that doctors use to describe the stage is the TNM system. Doctors use the results from diagnostic tests and scans to answer these questions:

Tumor (T): How large is the primary tumor? Where is it located?

Node (N): Has the tumor spread to the lymph nodes? If so, where and how many?

Metastasis (M): Has cancer spread to other parts of the body? If so, where and how much?

The results are combined to determine the stage of cancer for each person.

There are 5 stages: stage 0 (zero), which is non-invasive ductal carcinoma in situ (DCIS), and stages I through IV (1 through 4), which are used for invasive breast cancer. The stage provides a common way of describing cancer, so doctors can work together to plan the best treatments.

Staging can be clinical or pathological. Clinical staging is based on the results of tests done before surgery, which may include physical examinations, mammograms, ultrasound, and MRI scans. Pathologic staging is based on what is found during surgery to remove breast tissue and lymph nodes. The results are usually available several days after surgery. In general, pathological staging provides the most information to determine a patient’s prognosis.

Related Conferences:

Related societies and associations:

Track 8: Lifestyle and Breast Cancer

Lifestyle changes are shown to be important in the prevention of breast cancer. Diet, physical activity, smoking, alcohol use, and vitamin and mineral use are key factors influencing the risk of breast cancer among women. Because these factors are related to each other, it is difficult to assess their individual roles in breast cancer. Some of these factors are alterable, meaning that women can decrease their risk of breast cancer by changing their behaviour. Breast cancer is associated with a high rate of mortality and morbidity among women. Therefore, it is logical to try to find ways to decrease the risk of developing breast cancer. Lifestyle changes seem to be an easy, effective, and economical way to help prevent breast cancer. In women with a confirmed breast cancer diagnosis who are under radiotherapy treatment after undergoing a mastectomy, lifestyle changes are still very important. Some factors, such as smoking cessation and prevention of weight gain, may improve the long-term survival chances of these patients. Therefore, ways to increase women’s knowledge about the role of lifestyle changes in the prevention of breast cancer and in the survival of patients with diagnosed breast cancer should be considered and studied.

Related Conferences:

Related societies and associations:

Track 9: Alternative and Complementary Medicine

Medicine that is used along with conventional medicine is known as complementary medicine. On the other hand, alternative medicine is the medicine that is used in place of conventional medicine. Optimization of combined treatment by using conventional medicine and complementary medicine is very important for better results. Use of Mediation, Massage, Acupuncture, and herbs come under the category of complementary medicine. Studies have shown that the intake of supplements like vitamins can increase the risk of breast cancer, as some supplements might be having anti-cancer properties. So, alternative, complementary medicine and intake of supplements can minimize the risk of breast cancer.

Related Conferences:

Related societies and associations:

Track 10: Immunology and Breast Cancer

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.

Immunotherapy is a type of biological therapy. Biological therapy is a type of treatment that uses substances made from living organisms to treat cancer.

As part of its normal function, the immune system detects and destroys abnormal cells and most likely prevents or curbs the growth of many cancers. For instance, immune cells are sometimes found in and around tumors. These cells, called tumor-infiltrating lymphocytes or TILs, are a sign that the immune system is responding to the tumor. People whose tumors contain TILs often do better than people whose tumors don’t contain them.

Even though the immune system can prevent or slow cancer growth, cancer cells have ways to avoid destruction by the immune system. For example, cancer cells may:

Have genetic changes that make them less visible to the immune system.
Have proteins on their surface that turn off immune cells.
Change the normal cells around the tumor so they interfere with how the immune system responds to the cancer cells.

Immunotherapy helps the immune system to better act against cancer.

Related Conferences:

Related societies and associations:

Track 11: Breast Cancer: Survivorship

Having no signs of cancer after finishing treatment is what we say Survivorship or we can also say living with, through and beyond cancer. According to this definition, cancer survivorship begins at diagnosis and includes people who continue to have treatment over the long term, to either reduce the risk of recurrence or to manage chronic disease.

Survivorship is one of the most complicated parts of having cancer. This is because it is different for everyone.

Survivors may experience a mixture of strong feelings, including joy, concern, relief, guilt, and fear. Some people say they appreciate life more after a cancer diagnosis and have gained a greater acceptance of themselves. Others become very anxious about their health and are uncertain about coping with everyday life. Some people may even prefer to put the experience behind them and feel that their lives have not changed in a major way.

Every survivor has individual concerns and challenges. With any challenge, a good first step is being able to recognize your fears and talk about them. Effective coping requires:

Understanding the challenge you are facing
Thinking through solutions
Asking for and allowing the support of others
Feeling comfortable with the course of action you choose

Related Conferences:

Related societies and associations:

Track 12: Male Breast Cancer

Male breast cancer is rare cancer that forms in the breast tissue of men. Though breast cancer is most commonly thought of as a disease that affects women, breast cancer does occur in men.

Male breast cancer is most common in older men, though it can occur at any age.

Men diagnosed with male breast cancer at an early stage have a good chance for a cure. Treatment typically involves surgery to remove the breast tissue. Other treatments, such as chemotherapy and radiation therapy, may be recommended based on your particular situation.

Related Conferences:

Related societies and associations:

Track 13: Breast Cancer: Case Study

Breast cancer is quite rare in very young women. It is a disease primarily of older women, with 75% of cases occurring in women over 50 years of age. Only 6.5% of cases occur in women under 40 years of age, and a mere 0.6% of cases in women under 30 years of age. Thus, in the U.S., only about 1,200 cases of breast cancer occur in women under 30 years of age each year. Similarly, any such studies, which prove deviation from the normal outline, have been considered under case study.

Related Conferences:

Related societies and associations:

Track 14: Breast Cancer and Nursing

Oncology nurses are such important components of our care. They interact directly with patients in a way that allows them to monitor what's going on at a granular level. Oncology nurses are great at making sure they are staying on the pulse of patient symptoms, not only when they're in the clinic, but when they call in with symptoms. More and more people are using telemedicine to report their symptoms.

Oncology nurses are trained to recognize the common side effects that we see, and even some of the less common ones. To intervene early is so important. Things like diarrhea and dehydration—we need to know about those and monitor them early. Things like complications of chemo that are also common with low white blood cell counts and infections or fevers, those need to be intervened right away. The oncology nurse can intervene in not only assessment but also in recommending the types of supportive care approaches that would be critical to keeping patients out of trouble.

Related Conferences:

Related societies and associations:

Track 15: Industries and Investors Meet

Breast Cancer being prevalent among various types of cancer, the drug market has driven up. But there are factors, which can hinder the drug market like the risk of failure of cancer drugs and therapies, side effects of cancer therapies, high cost of drug development and cost of research in this area. Breast cancer is becoming the most common cause of death of women. The girls and young age women are at high risk of cancer-causing agents. Research in field of advanced cancer drugs and personalized medicine provides opportunities to the companies in developed and developing countries in the area of pharmaceuticals and biotechnology.

Related Conferences:

Related societies and associations:

Track 16: Call for Workshops/Symposia

Discussion on latest technologies and applications in breast cancer treatment is important to improve the treatment of breast cancer as well as for awareness against breast cancer. Breast cancer is the most affecting disease among women worldwide. Chances of survival from breast cancer are higher today than ever before. Latest technologies and outstanding clinical applications have helped the mortality to reduce. Latest technological advancements or advanced treatment methodologies can be shared during the workshop between the speakers and participants.

Related Conferences:

Related societies and associations:

Track 17: Breast Cancer and Pregnancy

Pregnancy and breast cancer impact each other in many ways. Whether you are cancer-free, newly diagnosed or a long-term survivor, you may have questions about how having children and breast cancer may be related. Understanding how childbearing impacts your breast cancer risk, and for survivors, how it relates to the chances of survival after treatment is important. And, for newly diagnosed younger women, understanding how some therapies may affect your fertility may be helpful in exploring options for having a child after treatment ends.

Related Conferences:

Related societies and associations:

Track 18: Controversies in Breast Cancer

Globally, breast cancer (BC) is one of the most frequently diagnosed cancers. More than 1.6 million new cases of BC are identified among women, according to the recent worldwide available data. In addition, the cumulative incidence of BC rose by more than a quarter between 1980 and 2010 among 187 countries. This raise has been succeeded thanks to BC awareness and early detection of breast malignancy.

Taking into consideration the progress in diagnosis and treatment, it is inevitable that some controversies will come up in daily clinical practice. The aim of this review is to illustrate some of these conflicting issues and make them less “ambiguous”. Especially, in the diagnosis field, the subjects which are discussed below are mammography, breast tomosynthesis, 3D ultrasound, shear wave elastography, magnetic resonance imaging, fine needle aspiration and core biopsy, computed tomography, positron emission tomography-computed tomography (PET-CT), axillary node dissection, sentinel lymph node biopsy, internal mammary node sampling and negative margin widths. As for the controversial issues based on treatment, these are partial breast radiotherapy, breast reconstruction, sequence of radiotherapy and chemotherapy, hormotherapy and biphosphonates. However, the follow-up of BC survivors has not been overlooked.

Related Conferences:

Related societies and associations:

Track 19: Current and Future State

Prevention, Detection and cure of breast cancer depend upon a better understanding of biology of breast cancer cell. Understanding of signal transduction and protein interactions at molecular level helps in understanding the biology of breast cancer cell more clearly. Imaging techniques are there which help in early detection of Breast Cancer. Molecular Imaging helps in detection of different changes that occurs in body due to the therapy used for treatment. Use of different therapeutic and gene targeted cells for the treatment of breast cancer will affect mortality and modalities in the future. Molecular Imaging in Oncology, Gene therapy is new emerging era in the field of breast cancer treatment. Challenges are there using the molecular imaging for the treatment of breast cancer.

Related Conferences:

Related societies and associations:

The global breast cancer therapy market is expected to register a CAGR of 8.5% during the forecast period 2018-2023. The high incidence rate of breast cancer is now becoming a concern, and several pharmaceutical companies are increasingly investing in research on breast cancer. Thus, the market is expected to grow. Statistics say that around 50% of breast cancer cases and more than 58% of deaths occur in less developed countries. The National Cancer Institute has estimated that 246,660 cases of breast cancer were diagnosed in 2016. The high incidence and prevalence rate show that the breast cancer therapeutics market will boost over the forecast period. Today, an increasing number of countries are adopting early cancer detection programs, around the world. If these initiatives continue, the demand for breast cancer therapeutics is bound to increase, with most of the cases being detected in the early stages. Along with the other factors, such as high investments on R&D, and the advancements in cancer biology and pharmacology promoting drug development, are driving the market. North America dominates the market for breast cancer therapy, due to the fact that the prevalence of breast cancer is on the rise in this region, along with an increase in R&D funding through public and private sectors. Asia-Pacific region is expected to grow at a significant pace, over the forecast period.

What we Do and Don’t Know About Corona Virus!!

A rapidly evolving health story broke in late December 2019 when a novel illness originating in Wuhan, China (the epicenter of the outbreak) shocked in the news. Reports of a number of infected people sharply rose, and isolated cases of this new coronavirus — also renamed 2019-nCoV by scientists — have appeared in several countries due to international travel. At this time, almost 20,438 confirmed cases and over 350 deaths have occurred in China, according to an article in the New York Times.

Fortunately, public health officials in many countries have put measures in place to help prevent further spread of the virus. These measures include health screenings at major international airports for people traveling from Wuhan. In China, travel restrictions are in effect.

With information changing so quickly and every news report about the virus seeming to raise the stakes, you may be wondering how worried you should be. Here’s a primer on what we do and don’t know about this virus and what it may mean for you. While there is much more to know and understand about the virus, public health officials, medical experts, and scientists are working in collaboration to get a cure.

What is a coronavirus?

Coronaviruses are an extremely common cause of colds and other upper respiratory infections. These viruses are zoonoses, which means they can infect certain animals and spread from one animal to another. A coronavirus can potentially spread to humans, particularly if certain mutations in the virus occur.

Chinese health authorities reported a group of cases of viral pneumonia to the World Health Organization (WHO) in late December 2019. Many of the ill people had contact with a seafood and animal market in Wuhan, a large city in eastern China, though it has since become clear that the virus can spread from person to person.

What are the symptoms of coronavirus?

The symptoms can include cough, possibly with a fever and shortness of breath. There are some early reports of non-respiratory symptoms, such as nausea, vomiting, or diarrhea. Many people recover within a few days. However, some people — especially the very young, elderly, or people who have a weak immune system — may develop a more serious infection, such as bronchitis or pneumonia.

Is there any treatment for coronaviruses?

Scientists are working hard to understand the virus, and Chinese health authorities have posted their full genome in international databases. Currently, there are no approved antivirals for this particular coronavirus, so treatment is supportive. For the sickest patients with this illness, specialized, aggressive care in an intensive care unit (ICU) can be lifesaving.

Should you worry about catching this virus?

Unless you’ve been in close contact with someone who has the coronavirus — which right now, typically means a traveler from Wuhan, China who actually has the virus — you’re likely to be safe. In the US, for example, only two cases of the virus have been confirmed so far, although this is likely to change.

While we don’t yet understand the particulars of how this virus spreads, coronaviruses usually spread through droplets containing large particles that typically can only be suspended in the air for three to six feet before dissipating. By contrast, measles or varicella (chickenpox) spread through smaller droplets over much greater distances. Some coronaviruses also have been found in the stool of certain individuals.

So it’s likely that coughs or sneezes from an infected person may spread the virus. It’s too early to say whether another route of transmission, fecal-oral contact, might also spread this particular virus.

Basic infectious disease principles are key to curbing the spread of this virus. Wash your hands regularly. Cover coughs and sneezes with a tissue (then throw it away), or your inner elbow. Avoid touching your eyes, nose, or mouth with your hands. Stay home from work or school if you have a fever. Stay away from people who have signs of a respiratory tract infection, such as the runny nose, coughing, and sneezing.

In the US, the average person is at extremely low risk of catching this novel coronavirus. This winter, in fact, we are much more likely to get influenza B — the flu — than any other virus: one in 10 people have influenza each flu season. It’s still not too late to get a flu shot, an easy step toward avoiding the flu. If you do get the flu despite having gotten the vaccine, studies show that severe illness, hospitalization, ICU admission, and death are less likely to occur.

The bottom line

Given the current spread of this virus and the pace and complexity of international travel, the number of cases and deaths will likely to continue to climb. We should not panic, even though we are dealing with a serious and novel pathogen. Public health teams are assembling. Lessons learned from other serious viruses, such as SARS and MERS, will help. As more information becomes available, public health organizations like the Centers for Disease Control (CDC) in the US and the World Health Organization (WHO) will be sharing key information and strategies worldwide.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	September 17-18, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

2^nd International Conference on Breast Pathology and Cancer Diagnosis September 17-18, 2020 Vienna, Austria

Recommended Global Pathology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Breast Pathology 2020

Important Dates & Deadlines

About Breast Pathology..!!

Audience:

Conference Highlights:

What is Breast Cancer?

Target Audience

Objective:

Benefits of Attending the Breast Pathology and Cancer Diagnosis Conference

What we Do and Don’t Know About Corona Virus!!

What is a coronavirus?

What are the symptoms of coronavirus?

Is there any treatment for coronaviruses?

Should you worry about catching this virus?

The bottom line

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues